Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hesketh

Showing results (211-220 of 248) with videos related to

Pageof 25
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2Paul J Hesketh, Kari Chansky, Antoinette J Wozniak, et al.
Cancer|April 25, 2003
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomitingSant P Chawla, Steven M Grunberg, Richard J Gralla, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027)Paul J Hesketh, Kari Chansky, Derick H M Lau, et al.
Cancer|August 17, 2005
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapyJørn Herrstedt, Hyman B Muss, David G Warr, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914Paul J Hesketh, Jason McCoy, Frank R Dunphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2006
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006, Mark G Kris, Paul J Hesketh, et al.
Communications Biology|June 28, 2025
Author Correction: Distinct virome compositions and lack of viral diversification indicate that viral spillover is a dead-end between the western honey bee and the common eastern bumblebeeDean A McKeown, Elaine Evans, Jessica Helgen, et al.
The ISME Journal|December 10, 2024
Host-specific viral predation network on coral reefsNatascha S Varona, Poppy J Hesketh-Best, Felipe H Coutinho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I studyH Safran, T P King, H Choy, et al.
Communications Biology|June 16, 2025
Distinct virome compositions and lack of viral diversification indicate that viral spillover is a dead-end between the western honey bee and the common eastern bumblebeeDean A McKeown, Elaine Evans, Jessica Helgen, et al.
Pageof 25

Showing results (211-220 of 248) with videos related to

Sort By:
Pageof 25
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2Paul J Hesketh, Kari Chansky, Antoinette J Wozniak, et al.
Cancer|April 25, 2003
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomitingSant P Chawla, Steven M Grunberg, Richard J Gralla, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027)Paul J Hesketh, Kari Chansky, Derick H M Lau, et al.
Cancer|August 17, 2005
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapyJørn Herrstedt, Hyman B Muss, David G Warr, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914Paul J Hesketh, Jason McCoy, Frank R Dunphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2006
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006, Mark G Kris, Paul J Hesketh, et al.
Communications Biology|June 28, 2025
Author Correction: Distinct virome compositions and lack of viral diversification indicate that viral spillover is a dead-end between the western honey bee and the common eastern bumblebeeDean A McKeown, Elaine Evans, Jessica Helgen, et al.
The ISME Journal|December 10, 2024
Host-specific viral predation network on coral reefsNatascha S Varona, Poppy J Hesketh-Best, Felipe H Coutinho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I studyH Safran, T P King, H Choy, et al.
Communications Biology|June 16, 2025
Distinct virome compositions and lack of viral diversification indicate that viral spillover is a dead-end between the western honey bee and the common eastern bumblebeeDean A McKeown, Elaine Evans, Jessica Helgen, et al.
Pageof 25